Hallucinations, délires, anxiété, TCSP : les traitements qui fonctionnent dans la MCL - Pr. F Blanc

This essential video presents the new 2024–2025 French guidelines for the treatment of behavioral and psychological symptoms (BPS) in Lewy body disease (LBD). Professor Frédéric Blanc and his team detail, for each major symptom—hallucinations, delusions, REM sleep behavior disorder, anxiety, depression, frontal lobe syndrome, and catatonia—the validated approaches, effective medications, which should be prioritized, and which should be absolutely avoided due to the very high sensitivity of LBD. • When to use Donepezil, Rivastigmine, Clozapine, Quetiapine, or Pimavanserin? • Why are conventional neuroleptics dangerous for 80% of patients? • What treatments are available for anxiety, depression, or frontal lobe syndrome? • How to treat BPS and prevent severe forms? • How to recognize and manage catatonia? These new therapeutic recommendations represent a major turning point for healthcare professionals, caregivers, and all organizations supporting individuals with Lewy body dementia (LBD). You can access all the new recommendations for managing psychological and behavioral symptoms (PBDS) in neurocognitive disorders via the following link: https://sfgg.org/espace-presse/commun... #LewyBodyDisorder #Hallucinations #Delirium #BDSP #Anxiety #Depression #FrontalSyndrome #Catatonia #A2LBD #Recommendations2025